McHale Duncan
- SEC CIK
- 0001738896
No open-market purchases or sales filed in the past year.
Current role at each company
- EVLO Evelo Biosciences, Inc.Chief Medical Officeras of Nov 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McHale Duncan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2023 (view filing)8:32 PM ET | Nov 8 | Same day | McHale DuncanChief Medical Officer | SSale | −3.10K | $0.33 | −$1.02K | −15.4%17.0K after | 10b5-1 |
| Nov 3, 2023 (view filing)4:11 PM ET | Nov 2 | 1 day | McHale DuncanChief Medical Officer | SSale | −6.85K | $0.33 | −$2.26K | −33.5%13.6K after | 10b5-1 |
| Aug 9, 2023 (view filing) | Aug 8 | 1 day | McHale DuncanChief Medical Officer | SSale | −3.43K | $9.51 | −$32.7K | −30.2%7.94K after | 10b5-1 |
| May 10, 2023 (view filing)9:32 PM ET | May 8 | 2 days | McHale DuncanChief Medical Officer | SSale | −66.7K | $0.1255 | −$8.37K | −40.6%97.5K after | 10b5-1 |
| May 31, 2022 (view filing) | May 27 | 4 days | McHale DuncanChief Medical Officer | PPurchase | +34.2K | $1.46 | +$50.0K | New position34.2K after |